Table 3 3 month accelerated condition (40 °C/75% RH) assay analysis of wafer formulation.
From: Calcium alginate medicated dressing for enhanced absorption in diabetic foot ulcer management
3 month assay analysis result | |||||||
|---|---|---|---|---|---|---|---|
Standard name | Sample Weight | Dilution | Aliquot | Dilution | PPM | Potency | LC |
Linezolid | 50.41 | 50 | 2.5 | 50 | 50.41 | 99.79 | 0.5 |
1 | 2 | 3 | Mean | SD | %RSD | ||
|---|---|---|---|---|---|---|---|
Std area | 2,837,641 | 2,837,641 | 2,837,641 | 2,837,641 | 0 | 0.00 |
Sample name | Sample weight | Dilution | Aliquot | Dilution | Area | % Assay | |
|---|---|---|---|---|---|---|---|
Wafer formulation (3 M accelerated) | 150.54 | 10 | 0 | 0 | 2,783,784 | 98.67 |
